GlassScriptPhysician profile
Gregory Dane Fritz
NPI 1437644655
$22,781.22
in general payments reported to CMS, 2019-2025
12 companies · $12K in 2025
The $12K reported for 2025 was more than what 95% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,000 · 2022: $250 · 2023: $2,897 · 2024: $7,092 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $14K · Travel and Lodging: $4,749 · Food and Beverage: $2,948.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $13,833.76 |
| Travel and Lodging | $4,749.22 |
| Food and Beverage | $2,948.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $20,469.98 | 2021-2025 | Davinci Xi, Da Vinci Surgical System |
| W. L. Gore & Associates, INC. | $1,059.64 | 2024 | Gore Bio-A Tissue Reinforcement, Gore Enform Preperitoneal Biomaterial, Gore Synecor Biomaterial |
| Davol INC. | $702.94 | 2025 | Phasix Mesh |
| Takeda Pharmaceuticals U.S.A., INC. | $135.24 | 2024-2025 | Entyvio |
| Mesh Suture INC | $114.39 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $103.05 | 2025 | Xifaxan |
| Lilly USA, LLC | $77.41 | 2024-2025 | Omvoh |
| Teva Pharmaceuticals USA, INC. | $35.48 | 2025 | Truxima |
| Ethicon US, LLC | $23.93 | 2025 | Echelon; Endopath, Enseal, Harmonic |
| Abbvie INC. | $23.25 | 2025 | |
| Madrigal Pharmaceuticals | $19.42 | 2025 | Rezdiffra |
| Ardelyx, INC. | $16.49 | 2025 | Ibsrela |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Fritz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.